Delivery Order SPE2DB20D1004-SPE2DB23FG2J7

Award Date 7/18/23
Potential Completion Date 7/19/23
Potential Value $382
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $416.76 delivery order to Amerisourcebergen Drug Corporation for 30 packages of the 4 mg ondansetron orally disintegrating tablets. The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 7, 2023 under a firm fixed price contract. No additional details were provided regarding the original solicitation or whether this delivery order falls under a larger indefinite-delivery/indefinite-quantity contract...
The Defense Logistics Agency awarded a $3,883.91 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 packages of the 4 mg ondansetron orally disintegrating tablets. The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 8, 2023 to support the Department of Defense's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued under an existing...
The Defense Logistics Agency awarded a $312,540 delivery order to Amerisourcebergen Drug Corporation for ondansetron orally disintegrating tablets. Under the terms of the firm fixed price contract, Amerisourcebergen will provide 30,000 4mg ondansetron tablets to support the DLA's pharmaceutical distribution requirements. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a four day period from June 20th through June 21st, 2023. No subcontractors or set...
The Defense Logistics Agency awarded a $4,132 delivery order to Amerisourcebergen Drug Corporation for 30 packages of the 4mg ondansetron orally disintegrating tablets. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility to support Defense Logistics Agency requirements. The firm fixed price contract runs from August 16 to August 17, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency manages the...
The Defense Logistics Agency awarded a $10,548.45 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 packages of the 4 mg ondansetron orally disintegrating tablets. The prime contractor, Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 23, 2023 in support of the Defense Logistics Agency's medical supply needs. No set aside designation or...
The Defense Logistics Agency awarded a $20,056 delivery order contract to Amerisourcebergen Drug Corporation for ondansetron orally disintegrating tablets. Under this firm fixed price order, Amerisourcebergen will supply 30,000 units of the 4mg tablets to a facility in Conshohocken, Pennsylvania by September 8, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and is likely procuring these nausea medications to support military treatment facilities. No...
The Defense Logistics Agency awarded a $520 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 tablets of the 8 mg ondansetron orally disintegrating tablet. The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by June 28, 2023 in support of the Defense Logistics Agency's medical supply needs. No major subcontractors or set aside designations were indicated. The delivery order was awarded under an existing DLA...
<p>The Defense Logistics Agency awarded a $507.98 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 packages of the 4 mg ondansetron orally disintegrating tablets. The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 19, 2023 in support of the Defense Logistics Agency's medical supply needs. No major subcontractors or set aside designations were indicated in the award information.</p>
The Defense Logistics Agency awarded a $1,656.18 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 tablets of 4 mg ondansetron orally disintegrating tablets. The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 13, 2023 in support of the Defense Logistics Agency's medical supply needs. No major subcontractors or set aside designations were indicated. The delivery order was awarded under an existing DLA...
The Defense Logistics Agency awarded a $3,920.04 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 packages of the 4 mg ondansetron orally disintegrating tablets. The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 24, 2023 in support of DLA requirements. Amerisourcebergen Drug Corporation will perform under the contract from its corporate office. No set aside designation or subcontractors were identified....
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FG2J7
    Delivery Order

The Defense Logistics Agency awarded a $382,470 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 packages of the 4 mg ondansetron orally disintegrating tablets. The prime contractor will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by July 19, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified in the award information. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle to fulfill requirements for ondansetron tablets, an anti-nausea medication commonly used to prevent post-operative nausea and vomiting.

Generated 12/24/23, 5:27 AM